1. Home
  2. ARMP vs EPSN Comparison

ARMP vs EPSN Comparison

Compare ARMP & EPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$4.40

Market Cap

156.4M

Sector

Health Care

ML Signal

HOLD

Logo Epsilon Energy Ltd.

EPSN

Epsilon Energy Ltd.

HOLD

Current Price

$5.60

Market Cap

187.2M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARMP
EPSN
Founded
N/A
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
156.4M
187.2M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
ARMP
EPSN
Price
$4.40
$5.60
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
95.5K
131.1K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
4.01%
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$21.46
Revenue Growth
N/A
N/A
52 Week Low
$2.40
$4.20
52 Week High
$14.98
$6.65

Technical Indicators

Market Signals
Indicator
ARMP
EPSN
Relative Strength Index (RSI) 44.18 49.53
Support Level $4.36 $5.53
Resistance Level $5.60 $5.62
Average True Range (ATR) 0.52 0.21
MACD 0.07 -0.01
Stochastic Oscillator 27.38 47.59

Price Performance

Historical Comparison
ARMP
EPSN

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About EPSN Epsilon Energy Ltd.

Epsilon Energy Ltd is a North American on-shore focused independent natural gas and oil company engaged in the acquisition, development, gathering and production of natural gas and oil reserves. Its properties include Appalachian Basin-Pennsylvania, Permian Basin-Texas and New Mexico, Anadarko Basin-Oklahoma, Powder River Basin-Wyoming, Western Canadian Sedimentary Basin-Alberta, Canada. Its segments include The Upstream segment activities include acquisition, development and production of natural gas and oil reserves on properties within the United States and Canada; and The Gas Gathering segment partners with two other companies to operate a natural gas gathering system. The Upstream segment derives the majority of the revenue.

Share on Social Networks: